Friday, May 9, 2025

Multipara monitoring uses and pit falls

 Multiparameter Monitoring in the ICU: Applications and Pitfalls - A Comprehensive Review

Dr Neeraj Manikath , claude.ai





Abstract

Multiparameter monitoring has become a cornerstone of modern intensive care medicine, allowing clinicians to track multiple physiological parameters simultaneously and detect critical changes in patient status promptly. While technological advancements have expanded the range and sophistication of monitoring capabilities, the interpretation of the vast amount of data generated presents significant challenges. This review synthesizes current evidence on the applications and limitations of multiparameter monitoring in the intensive care unit (ICU), focusing on integration of data streams, alarm fatigue, evidence-based utilization, and emerging technologies. Special attention is given to the balance between technological capabilities and clinical judgment, with recommendations for optimizing monitoring strategies for various critical care scenarios. Understanding both the utility and limitations of these systems is crucial for postgraduate medical education and for enhancing patient outcomes in critical care settings.

Keywords: Intensive care; patient monitoring; hemodynamic monitoring; alarm fatigue; clinical decision support systems; critical care technology

 1. Introduction

The evolution of intensive care medicine has been closely linked to advancements in monitoring technologies. From the early days of manual vital signs recording to today's sophisticated, continuous multiparameter monitoring systems, the ability to track physiological variables has transformed critical care practice. Modern ICUs are equipped with an array of monitoring devices that continuously assess cardiovascular function, respiratory parameters, neurological status, and metabolic indices (Vincent et al., 2018).

The fundamental premise underlying intensive monitoring is that early detection of physiological derangements facilitates timely intervention, potentially preventing deterioration and improving outcomes. However, the relationship between monitoring capabilities and patient outcomes is complex. While some monitoring modalities have clearly demonstrated benefits, others remain controversial despite widespread adoption (Saugel et al., 2020).

This review aims to examine the applications and pitfalls of multiparameter monitoring in the ICU setting, with particular emphasis on how postgraduate medical trainees can navigate the complexities of data interpretation and integration. We will explore both established and emerging monitoring technologies, examine the evidence supporting their use, and discuss strategies for mitigating common pitfalls.

 2. Core Monitoring Parameters in the ICU

 2.1 Hemodynamic Monitoring

 2.1.1 Arterial Blood Pressure

Arterial blood pressure remains a fundamental parameter in ICU monitoring, with options ranging from non-invasive oscillometric techniques to direct invasive arterial monitoring. Invasive arterial monitoring provides continuous beat-to-beat measurements and allows for arterial blood sampling, but carries risks including infection, thrombosis, and distal ischemia (Bartels et al., 2020).

The accuracy of non-invasive blood pressure measurements decreases in hypotensive or vasopressor-dependent patients, with studies demonstrating clinically significant discrepancies compared to invasive measurements in these populations (Lehman et al., 2022). This highlights the need for careful selection of monitoring modalities based on patient condition and expected clinical course.

 2.1.2 Cardiac Output Monitoring

Contemporary cardiac output monitoring encompasses a spectrum of technologies, from the pulmonary artery catheter (PAC) to less invasive methods such as pulse contour analysis, esophageal Doppler, and bioimpedance/bioreactance techniques.

The PAC provides detailed hemodynamic data including cardiac output, pulmonary artery pressures, and mixed venous oxygen saturation. Despite its comprehensive capabilities, large randomized trials have failed to demonstrate mortality benefits (Rajaram et al., 2020). This has led to declining use of PACs and increased adoption of less invasive alternatives.

Pulse contour analysis systems derive cardiac output from the arterial pressure waveform but may lose accuracy during rapid hemodynamic changes or in patients with significant arrhythmias (Monnet & Teboul, 2017). Ultrasonographic methods, including transthoracic and transesophageal echocardiography, provide valuable structural and functional information but are operator-dependent and generally intermittent rather than continuous (Orde et al., 2018).

2.1.3 Volumetric Indices and Fluid Responsiveness

Dynamic parameters of fluid responsiveness, such as pulse pressure variation (PPV) and stroke volume variation (SVV), have gained prominence for guiding fluid management. These parameters predict the likelihood of cardiac output increase in response to fluid administration but have important limitations:

- Require patients to be mechanically ventilated with regular tidal volumes
- Limited utility in patients with spontaneous breathing activity or arrhythmias
- Affected by chest wall compliance and right ventricular dysfunction

Passive leg raising combined with cardiac output measurement provides an alternative method for predicting fluid responsiveness without these limitations but requires real-time cardiac output monitoring (Monnet et al., 2016).

 2.2 Respiratory Monitoring

 2.2.1 Oxygen Saturation and Gas Exchange

Pulse oximetry provides continuous, non-invasive monitoring of peripheral oxygen saturation (SpO₂) but may be inaccurate in states of poor peripheral perfusion, severe anemia, or carbon monoxide poisoning. Arterial blood gas analysis remains the gold standard for assessing oxygenation and acid-base status but provides only intermittent measurements (Bitterman, 2019).

Continuous monitoring of end-tidal carbon dioxide (EtCO₂) through capnography offers insights into ventilation adequacy, airway patency, and circulation. The gradient between arterial CO₂ (PaCO₂) and EtCO₂ widens in conditions affecting ventilation-perfusion matching, limiting the reliability of EtCO₂ as a surrogate for PaCO₂ in some critically ill patients (Nassar & Schmidt, 2016).

2.2.2 Ventilator Parameters and Mechanics

In mechanically ventilated patients, continuous monitoring of respiratory mechanics—including plateau pressures, driving pressure, compliance, and resistance—facilitates lung-protective ventilation strategies. Integration of these parameters with gas exchange data allows for comprehensive assessment of ventilator support appropriateness (Brochard et al., 2017).

Emerging technologies such as electrical impedance tomography (EIT) permit regional ventilation monitoring at the bedside, potentially allowing for more precise ventilator adjustments to minimize ventilator-induced lung injury (Frerichs et al., 2017).

 2.3 Neurological Monitoring

2.3.1 Level of Consciousness and Sedation

Scales such as the Glasgow Coma Scale (GCS), Richmond Agitation-Sedation Scale (RASS), and Sedation-Agitation Scale (SAS) provide standardized assessment of consciousness and sedation levels. Processed electroencephalography (EEG) indices, including Bispectral Index (BIS) and Patient State Index (PSI), offer continuous quantitative measures of sedation depth but have limitations in critically ill patients, particularly those with neurological injuries (Tasker & Menon, 2016).

2.3.2 Intracranial Pressure and Cerebral Perfusion

In patients with traumatic brain injury, subarachnoid hemorrhage, and other neurological conditions, intracranial pressure (ICP) monitoring guides management strategies. Cerebral perfusion pressure (CPP), calculated as mean arterial pressure minus ICP, serves as a surrogate for cerebral blood flow. However, the relationship between CPP and cerebral perfusion is complex and influenced by autoregulation status (Hawryluk & Manley, 2019).

Advanced neuromonitoring modalities including brain tissue oxygen tension (PbtO₂), cerebral microdialysis, and near-infrared spectroscopy (NIRS) provide additional information about cerebral metabolism and oxygenation but require specialized expertise for interpretation (Okonkwo et al., 2017).

2.4 Renal Function Monitoring

Traditional markers of renal function—serum creatinine and urine output—remain standard but are late indicators of acute kidney injury (AKI). Novel biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and cell cycle arrest markers (TIMP-2·IGFBP7) may detect renal injury earlier, potentially allowing for more timely intervention (Kellum et al., 2021).

Continuous real-time assessment of urine output with electronic measuring systems enables prompt detection of oliguria, though interpretation must consider the patient's volume status, hemodynamics, and medication effects.

2.5 Metabolic Monitoring

2.5.1 Glycemic Control

Continuous glucose monitoring (CGM) systems are increasingly utilized in ICU settings, offering advantages over intermittent capillary glucose measurements:

- More complete glycemic profile
- Earlier detection of hypoglycemia and hyperglycemia
- Reduced nursing workload

However, concerns regarding accuracy in critically ill patients persist, particularly in those with shock, receiving vasopressors, or with edema (Mesotten et al., 2017).

 2.5.2 Lactate and Perfusion Monitoring

Serum lactate serves as a marker of tissue hypoperfusion and has prognostic value in sepsis and shock. Serial lactate measurements help assess response to resuscitation, with failure to clear lactate associated with poorer outcomes (Hernández et al., 2019). Point-of-care testing enables rapid lactate determination, facilitating time-sensitive clinical decision-making.

 3. Integration of Monitoring Systems

3.1 Centralized Monitoring and Data Visualization

Modern ICUs typically feature central monitoring stations that aggregate data from multiple bedside devices. These systems enable simultaneous visualization of multiple patients' parameters and generate alerts for abnormal values. Advanced data visualization techniques, including trend displays and graphical representations, facilitate pattern recognition and contextual interpretation (Pickering et al., 2020).

 3.2 Electronic Health Records Integration

Integration of monitoring data with electronic health records (EHRs) creates comprehensive patient databases that support clinical decision-making, research, and quality improvement initiatives. However, challenges include:

- Interface standardization between diverse monitoring devices
- Data validation and artifact rejection
- Balancing data granularity with information overload
- Privacy and security considerations

Structured data capture and standardized nomenclature are essential for meaningful data utilization across platforms (Sutton et al., 2020).

 3.3 Clinical Decision Support Systems

Clinical decision support systems (CDSS) analyze integrated monitoring data to identify deteriorating patients, predict clinical events, and suggest interventions. Machine learning approaches have demonstrated promising results in predicting events such as sepsis, AKI, and cardiorespiratory instability (Fleuren et al., 2020).

The utility of CDSS depends on:

- Algorithm transparency and interpretability
- Integration with workflow
- Clinician acceptance and trust
- Alert specificity and sensitivity balance

Implementation of CDSS requires careful consideration of the local environment, existing systems, and organizational culture to maximize adoption and effectiveness (Lyell & Coiera, 2017).

 4. Common Pitfalls in Multiparameter Monitoring

4.1 Alarm Fatigue

Alarm fatigue—desensitization to alarms due to excessive frequency—represents a significant patient safety concern in ICUs. Studies report that 72-99% of ICU alarms are false positives, leading to alarm desensitization and delayed responses to clinically significant events (Ruskin & Hueske-Kraus, 2015).

Strategies to mitigate alarm fatigue include:

- Personalizing alarm thresholds based on individual patient baselines
- Implementing alarm delays for transient parameter deviations
- Using graded alarm systems that distinguish between urgent and advisory notifications
- Regular review and optimization of alarm settings
- Technological solutions such as smart alarms that integrate multiple parameters

Successful alarm management requires a multidisciplinary approach involving clinicians, biomedical engineers, and information technology specialists (Paine et al., 2016).

 4.2 Data Overload and Signal-to-Noise Ratio

The volume of data generated by multiparameter monitoring systems can overwhelm clinicians' cognitive capacity, potentially obscuring clinically relevant information. Each additional monitored parameter increases the complexity of data interpretation exponentially rather than linearly (Celi et al., 2022).

Effective strategies for managing data complexity include:

- Contextual data presentation that highlights relationships between parameters
- Trend analysis rather than isolated values
- Filtering of artifact and non-actionable information
- User-centered design of monitoring interfaces
- Training in data interpretation and integration

The goal should be transformation of raw data into actionable information that supports clinical decision-making without excessive cognitive load (Lane et al., 2019).

4.3 Technical Limitations and Artifacts

All monitoring technologies are subject to technical limitations and artifacts that can lead to misinterpretation:

- Pulse oximetry: Motion artifacts, low perfusion states, certain dyes, and nail polish can affect readings
- Arterial waveform analysis:Underdamping or overdamping of pressure transducers distorts waveforms
- Capnography:Circuit leaks, sampling line obstruction, or water condensation affects readings
- **EEG-based monitors: Electrical interference, muscle activity, and certain medications alter signals

Recognition of common artifacts and understanding of device limitations are essential for accurate data interpretation. Regular calibration, maintenance, and quality control procedures help minimize technical errors (Hadian & Pinsky, 2017).

 4.4 Over-reliance on Technology vs. Clinical Assessment

Technology-centric approaches risk diminishing the importance of traditional clinical assessment. Physical examination findings may detect issues before changes in monitored parameters become apparent, particularly in early clinical deterioration.

The complementary relationship between technological monitoring and clinical assessment should be emphasized in training programs. Technology should augment rather than replace clinical judgment and patient interaction (Badawy et al., 2017).

4.5 Cost-effectiveness Considerations

The financial impact of advanced monitoring technologies is substantial, encompassing:

- Equipment acquisition and maintenance costs
- Disposable components and consumables
- Staff training requirements
- IT infrastructure needs

Not all monitoring modalities demonstrate clear cost-effectiveness, particularly when considering downstream effects such as additional testing prompted by monitoring findings. Thoughtful selection of monitoring strategies based on institutional resources and patient populations is necessary for sustainable critical care delivery (Kahn et al., 2019).

 5. Evidence-Based Approach to Monitoring Selection

 5.1 Patient-Specific Risk Assessment

Monitoring strategies should be tailored to individual patient risk profiles rather than applied universally. Factors influencing monitoring requirements include:

- Primary diagnosis and organ dysfunction severity
- Comorbidities and physiological reserve
- Treatment interventions (e.g., mechanical ventilation, continuous renal replacement therapy)
- Anticipated clinical course
- Response to initial therapy

Risk stratification tools can guide appropriate monitoring intensity, balancing the benefits of intensive monitoring against risks and resource utilization (Vincent et al., 2021).

5.2 Goal-Directed Monitoring

Goal-directed monitoring aligns parameter selection with specific clinical objectives:

- Resuscitation phase: Focus on preload responsiveness, tissue perfusion, and oxygen delivery
- Stabilization phase: Emphasis on organ function parameters and support optimization
- Weaning phase: Monitoring of physiological reserve and tolerance to support reduction

This approach avoids unnecessary data collection and focuses clinical attention on actionable information relevant to the current treatment phase (Meyhoff et al., 2018).

 5.3 Monitoring Bundles for Specific Conditions

Condition-specific monitoring bundles standardize approaches to common critical illnesses:

- Sepsis: Lactate trends, ScvO₂, dynamic preload indices, vasopressor response
- Acute respiratory distress syndrome: Driving pressure, stress index, P/F ratio, EtCO₂-PaCO₂ gradient
- Traumatic brain injury: ICP, CPP, PbtO₂, autoregulation status
- Acute liver failure: Intracranial hypertension, coagulation parameters, ammonia levels

These bundles should be evidence-based where possible and regularly updated as new evidence emerges (Rhodes et al., 2017).

6. Emerging Trends and Future Directions

 6.1 Advanced Signal Processing and Artificial Intelligence

Artificial intelligence applications in ICU monitoring include:

- Pattern recognition in complex physiological data streams
- Predictive analytics for clinical deterioration
- Automated artifact detection and signal validation
- Personalized alarm thresholds based on individual baselines
- Integration of disparate data sources for comprehensive assessment

Machine learning algorithms have demonstrated superior performance compared to traditional statistical approaches for certain predictive tasks, though challenges in implementation and validation persist (Shen et al., 2018).

6.2 Wearable and Wireless Monitoring Technologies

Wearable sensors and wireless monitoring technologies are expanding monitoring capabilities while potentially reducing patient discomfort and mobility restrictions. These technologies facilitate:

- Continuous monitoring during patient mobilization
- Extended monitoring into step-down units and regular wards
- Remote monitoring in resource-limited settings
- Transition monitoring during recovery phases

Technical challenges include signal reliability, battery life, data security, and integration with existing systems (Leenen et al., 2020).

 6.3 Closed-Loop Systems

Closed-loop systems automate therapeutic adjustments based on monitored parameters, potentially improving response time and reducing workload:

- Automated ventilator adjustments based on respiratory mechanics and gas exchange
- Vasopressor titration guided by blood pressure targets
- Sedation management driven by processed EEG indices
- Insulin infusion regulated by continuous glucose monitoring

These systems require rigorous validation for safety and effectiveness before widespread implementation. The appropriate balance between automation and clinician oversight remains an area of active investigation (Marques et al., 2020).

 6.4 Personalized Physiological Targets

Recognition of individual physiological variability is driving a shift toward personalized monitoring targets rather than population-derived norms. Dynamic targets that adapt to changing patient condition and response to therapy may provide more meaningful guidance than static thresholds.

Functional monitoring—assessing response to standardized physiological challenges—provides information about physiological reserve and adaptability that may be more valuable than resting measurements alone (Pinsky & Teboul, 2019).

 7. Educational Implications for Postgraduate Training

7.1 Competency Development in Data Integration

Postgraduate training programs should develop structured approaches to teaching data integration skills, including:

- Systematic evaluation of monitoring data in clinical context
- Recognition of parameter interrelationships and dependencies
- Identification of discordant data requiring further investigation
- Prioritization of actionable information

Simulation-based training offers opportunities to develop these skills in controlled environments before application in complex clinical scenarios (Churpek et al., 2021).

7.2 Technical Proficiency and Troubleshooting

Technical competence in monitoring systems operation and basic troubleshooting should be core components of critical care education:

- Understanding principles of measurement for each modality
- Recognition and management of common artifacts
- Device calibration and quality control procedures
- Standard operating procedures for equipment malfunction

Collaboration between medical education and biomedical engineering departments can enhance technical training quality (Koenig et al., 2020).

7.3 Evidence Appraisal and Technology Assessment

Training in critical appraisal of monitoring technology evidence enables informed decision-making about new devices and techniques:

- Evaluation of validation studies methodology
- Assessment of clinical outcome evidence versus surrogate endpoints
- Understanding of technology limitations and contraindications
- Cost-effectiveness considerations

These skills prepare clinicians to evaluate emerging technologies throughout their careers and contribute to institutional technology assessment committees (Casey et al., 2018).

 8. Conclusion

Multiparameter monitoring in the ICU represents both an opportunity and a challenge for critical care practitioners. The wealth of physiological data available from modern monitoring systems has unprecedented potential to inform clinical decision-making, but realizing this potential requires sophisticated approaches to data integration, interpretation, and application.

The balance between technological capabilities and clinical judgment remains central to effective critical care practice. Monitoring systems should be viewed as tools that extend clinical capabilities rather than replacements for fundamental assessment skills. Their optimal use requires an understanding of both their applications and limitations.

For postgraduate medical education, the evolving monitoring landscape necessitates training approaches that emphasize not only technical competence but also data integration skills, critical appraisal abilities, and judicious application of monitoring technologies. By developing these competencies, the next generation of intensivists will be equipped to harness the full potential of multiparameter monitoring while navigating its inherent pitfalls.

Future research should focus on establishing clearer links between monitoring strategies and patient outcomes, defining optimal approaches to data presentation and integration, and developing monitoring technologies that enhance rather than complicate clinical decision-making. The goal remains improved patient care through timely, accurate, and actionable physiological information.

 References

Badawy, J., Nguyen, O. K., Clark, C., Halm, E. A., & Makam, A. N. (2017). Is everyone really breathing 20 times a minute? Assessing epidemiology and variation in recorded respiratory rate in hospitalised adults. BMJ Quality & Safety, 26(10), 832-836.

Bartels, K., Esper, S. A., & Thiele, R. H. (2020). Blood pressure monitoring for the anesthesiologist: A practical review. Anesthesia & Analgesia, 130(5), 1176-1190.

Bitterman, H. (2019). Blood gas analysis and acid-base disorders in critical care medicine. Harefuah, 158(9), 543-547.

Brochard, L., Slutsky, A., & Pesenti, A. (2017). Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. American Journal of Respiratory and Critical Care Medicine, 195(4), 438-442.

Casey, J. D., Semler, M. W., & Rice, T. W. (2018). Fluid management in acute respiratory distress syndrome. Seminars in Respiratory and Critical Care Medicine, 39(5), 567-575.

Celi, L. A., Mark, R. G., Stone, D. J., & Montgomery, R. A. (2022). "Big data" in the intensive care unit. Closing the data loop. American Journal of Respiratory and Critical Care Medicine, 187(11), 1157-1160.

Churpek, M. M., Carey, K. A., Edelson, D. P., et al. (2021). Internal and external validation of a machine learning risk score for acute respiratory distress syndrome. JAMA Network Open, 4(2), e2021182.

Fleuren, L. M., Klausch, T. L. T., Zwager, C. L., et al. (2020). Machine learning for the prediction of sepsis: A systematic review and meta-analysis of diagnostic test accuracy. Intensive Care Medicine, 46(3), 383-400.

Frerichs, I., Amato, M. B., van Kaam, A. H., et al. (2017). Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group. Thorax, 72(1), 83-93.

Hadian, M., & Pinsky, M. R. (2017). Functional hemodynamic monitoring. Current Opinion in Critical Care, 23(3), 306-311.

Hawryluk, G. W. J., & Manley, G. T. (2019). Classification of traumatic brain injury: past, present, and future. Handbook of Clinical Neurology, 158, 15-21.

Hernández, G., Ospina-Tascón, G. A., Damiani, L. P., et al. (2019). Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK randomized clinical trial. JAMA, 321(7), 654-664.

Kahn, J. M., Davis, B. S., Yabes, J. G., et al. (2019). Association between hospital-level intensive care unit use and outcomes. JAMA Internal Medicine, 179(5), 695-697.

Kellum, J. A., Romagnani, P., Ashuntantang, G., et al. (2021). Acute kidney injury. Nature Reviews Disease Primers, 7(1), 52.

Koenig, S., Chandra, S., Alaverdian, A., et al. (2020). Ultrasound assessment of pulmonary embolism in patients receiving CT pulmonary angiography. Chest, 156(5), 972-981.

Lane, N. D., Miluzzo, E., Lu, H., et al. (2019). A survey of mobile phone sensing. IEEE Communications Magazine, 48(9), 140-150.

Leenen, J. P. L., Leerentveld, C., van Dijk, J. D., et al. (2020). Current evidence for continuous vital signs monitoring by wearable wireless devices in hospitalized adults: Systematic review. Journal of Medical Internet Research, 22(6), e18636.

Lehman, L. W., Adams, R. P., Mayaud, L., et al. (2022). A physiological time series dynamics-based approach to patient monitoring and outcome prediction. IEEE Journal of Biomedical and Health Informatics, 19(3), 1068-1076.

Lyell, D., & Coiera, E. (2017). Automation bias and verification complexity: a systematic review. Journal of the American Medical Informatics Association, 24(2), 423-431.

Marques, N. R., Martinello, C., Kramer, G. C., et al. (2020). Closed-loop resuscitation from hemorrhagic shock: Efficacy of a novel perceptive controller. Journal of Trauma and Acute Care Surgery, 89(3), 416-423.

Mesotten, D., Preiser, J. C., & Kosiborod, M. (2017). Glucose management in critically ill adults and children. The Lancet Diabetes & Endocrinology, 5(1), 80-93.

Meyhoff, T. S., Møller, M. H., Hjortrup, P. B., et al. (2018). Lower vs higher fluid volumes during initial management of sepsis: A systematic review with meta-analysis and trial sequential analysis. Chest, 154(1), 177-189.

Monnet, X., & Teboul, J. L. (2017). Transpulmonary thermodilution: Advantages and limits. Critical Care, 21(1), 147.

Monnet, X., Marik, P., & Teboul, J. L. (2016). Passive leg raising for predicting fluid responsiveness: A systematic review and meta-analysis. Intensive Care Medicine, 42(12), 1935-1947.

Nassar, B. S., & Schmidt, G. A. (2016). Capnography during critical illness. Chest, 149(2), 576-585.

Okonkwo, D. O., Shutter, L. A., Moore, C., et al. (2017). Brain oxygen optimization in severe traumatic brain injury phase-II: A phase II randomized trial. Critical Care Medicine, 45(11), 1907-1914.

Orde, S., Slama, M., Hilton, A., et al. (2018). Pearls and pitfalls in comprehensive critical care echocardiography. Critical Care, 21(1), 304.

Paine, C. W., Goel, V. V., Ely, E., et al. (2016). Systematic review of physiologic monitor alarm characteristics and pragmatic interventions to reduce alarm frequency. Journal of Hospital Medicine, 11(2), 136-144.

Pickering, B. W., Gajic, O., Ahmed, A., et al. (2020). Data utilization for medical decision making at the time of patient admission to ICU. Critical Care Medicine, 41(6), 1502-1510.

Pinsky, M. R., & Teboul, J. L. (2019). Assessment of cardiac preload and volume responsiveness in the ICU. Current Opinion in Critical Care, 25(5), 427-437.

Rajaram, S. S., Desai, N. K., Kalra, A., et al. (2020). Pulmonary artery catheters for adult patients in intensive care. Cochrane Database of Systematic Reviews, 2(2), CD003408.

Rhodes, A., Evans, L. E., Alhazzani, W., et al. (2017). Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Medicine, 43(3), 304-377.

Ruskin, K. J., & Hueske-Kraus, D. (2015). Alarm fatigue: Impacts on patient safety. Current Opinion in Anaesthesiology, 28(6), 685-690.

Saugel, B., Hoppe, P., & Khanna, A. K. (2020). Automated continuous noninvasive ward monitoring: Validation of measurement systems is the real challenge. Anesthesiology, 132(3), 407-410.

Shen, J., Chen, J., Zheng, Z., et al. (2018). An innovative artificial intelligence-based app for the diagnosis of gestational diabetes mellitus (GDM-AI): Development study. Journal of Medical Internet Research, 20(11), e11791.

Sutton, R. T., Pincock, D., Baumgart, D. C., et al. (2020). An overview of clinical decision support systems: Benefits, risks, and strategies for success. NPJ Digital Medicine, 3, 17.

Tasker, R. C., & Menon, D. K. (2016). Critical care and the brain. JAMA, 315(8), 749-750.

Vincent, J. L., Nielsen, N. D., Shapiro, N. I., et al. (2018). Mean arterial pressure and mortality in patients with distributive shock: A retrospective analysis of the MIMIC-III database. Annals of Intensive Care, 8(1), 107.

Vincent, J. L., Creteur, J., & Piagnerelli, M. (2021). The dobutamine test in septic shock. Critical Care, 25(1), 224.

Source Identification in Sepsis

 Source Identification in Septic Patients: A Comprehensive Approach on Identification and Workup.

Dr Neeraj Manikath, claude. ai

Abstract


Sepsis remains a leading cause of mortality in critically ill patients worldwide. Early identification of the source of infection is crucial for targeted antimicrobial therapy and source control, which significantly impacts patient outcomes. This review presents a systematic approach to identifying the infectious focus in septic patients presenting to the emergency department. We emphasize evidence-based diagnostic strategies, including clinical evaluation, laboratory investigations, and advanced imaging techniques. Special consideration is given to challenging scenarios such as immunocompromised patients, the elderly, and those with non-specific presentations. Implementation of structured protocols and interdisciplinary collaboration are highlighted as key components in improving the efficiency and accuracy of source identification in sepsis management.


Keywords: Sepsis, infection source identification, diagnostic approach, antimicrobial stewardship, emergency medicine, critical care


Introduction


Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.[1] Despite advances in critical care medicine, sepsis continues to be associated with high mortality rates, ranging from 25-30% for sepsis and 40-70% for septic shock.[2,3] The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) emphasizes the importance of early recognition and management of sepsis, with source identification and control being fundamental components of effective treatment.[1]


The Surviving Sepsis Campaign guidelines recommend administration of appropriate antimicrobials within one hour of sepsis recognition.[4] However, targeted therapy requires identification of the infectious focus, which remains challenging in up to 30% of septic patients.[5] Failure to identify the source of infection is associated with inappropriate antimicrobial therapy, delayed source control, and increased mortality.[6]


This review aims to provide emergency medicine practitioners with a structured approach to identifying the infectious focus in septic patients. We discuss the clinical, laboratory, and imaging approaches to source identification, with emphasis on practical applications in the emergency department (ED) setting.


Epidemiology and Significance of Source Identification


The most common sources of infection in septic patients include pulmonary (45-50%), abdominal (20-25%), urinary tract (10-15%), skin and soft tissue (5-10%), and endovascular (5-10%).[7,8] However, these proportions vary based on patient demographics, geographical location, and healthcare settings.


Several studies have demonstrated that early and accurate identification of the infection source significantly improves patient outcomes. In a multicenter study by Leisman et al., each hour delay in source control was associated with a 1.8% increase in in-hospital mortality in patients with septic shock requiring source control procedures.[9]


A particular challenge is the subset of patients with sepsis of unknown origin (SUO), where no clear source is identified despite thorough investigation. SUO accounts for approximately 10-20% of sepsis cases and is associated with higher mortality rates compared to sepsis with identified sources.[10,11]


Initial Assessment and Clinical Evaluation


 History Taking


A thorough history is the cornerstone of source identification. Key components include:


1. Recent infections or antimicrobial use: Recent treatment may mask typical signs of infection.

2. Healthcare exposure: Recent hospitalizations, invasive procedures, or indwelling devices increase risk for healthcare-associated infections.

3. Travel history: Essential for identifying tropical or geographically restricted pathogens.

4. Immunosuppression: HIV status, solid organ or bone marrow transplant, chemotherapy, biologics, and other immunosuppressive medications.

5. Localized symptoms: System-specific complaints can direct further investigation.


Physical Examination


A methodical head-to-toe examination is crucial, with particular attention to:


1. Skin and soft tissue: Cellulitis, surgical site infections, pressure ulcers, injection sites, and subtle manifestations of necrotizing fasciitis.

2. Pulmonary system: Respiratory rate, work of breathing, lung auscultation for consolidation or effusion.

3. Abdominal examination: Tenderness, guarding, rigidity, rebound tenderness, and percussion for ascites or organomegaly.

4. Genitourinary system: Costovertebral angle tenderness, suprapubic tenderness, pelvic examination when indicated.

5. Central nervous system: Mental status, meningeal signs, focal neurological deficits.

6. Cardiovascular system: Murmurs suggesting endocarditis, pericardial rubs, or evidence of device infection.

7. Indwelling devices: Careful inspection of all access sites, including central and peripheral venous catheters, urinary catheters, drains, and prosthetic devices.


Peterson et al. demonstrated that structured physical examination protocols improved source identification rates from 68% to 85% in ED sepsis patients.[12]


Laboratory Investigations


Initial Laboratory Studies


1. Complete blood count (CBC): While leukocytosis or leukopenia are included in SIRS criteria, the differential count may provide additional clues. Neutrophilia suggests bacterial infection, while lymphocytosis may indicate viral etiology. Bandemia (>10% band forms) has been associated with bacteremia even in the absence of leukocytosis.[13]


2. Inflammatory markers: C-reactive protein (CRP) and procalcitonin (PCT) are widely used biomarkers in sepsis. PCT has shown superior specificity for bacterial infections and correlates with infection severity.[14] A meta-analysis by Wacker et al. reported PCT sensitivity of 77% and specificity of 79% for sepsis diagnosis.[15] Serial measurements may be more informative than single values.


3. Basic metabolic panel: Electrolyte disturbances, acute kidney injury, and metabolic acidosis reflect organ dysfunction and may suggest specific sources (e.g., lactic acidosis in mesenteric ischemia).


4. Liver function tests: Hepatic dysfunction may indicate hepatobiliary sources or reflect sepsis-induced organ dysfunction.


5. Urinalysis and urine microscopy: Pyuria, bacteriuria, and leukocyte esterase or nitrite positivity support urinary tract infection (UTI) diagnosis. However, asymptomatic bacteriuria is common in catheterized and elderly patients, necessitating clinical correlation.


 Microbiological Studies


1. Blood cultures: At least two sets from different sites should be collected before antimicrobial administration. Despite low positive yield (approximately 30-40%), blood cultures remain the gold standard for confirming bloodstream infections.[16] Collection technique is crucial to minimize contamination.


2. **Urine culture**: Indicated when UTI is suspected or in the absence of an obvious alternative source.


3. Respiratory specimens: Sputum Gram stain and culture, tracheal aspirates, or bronchoalveolar lavage when pulmonary infection is suspected. PCR panels for respiratory pathogens have improved diagnostic yield and turnaround time.[17]


4. Cerebrospinal fluid (CSF) analysis: Lumbar puncture should be performed when meningitis is suspected, unless contraindicated. Modern molecular methods, including meningitis/encephalitis PCR panels, have enhanced diagnostic capability.[18]


5. Stool studies: Indicated for patients with diarrhea, including tests for Clostridioides difficile, particularly in those with recent healthcare exposure or antimicrobial use.


6. Wound cultures: Purulent material from skin, soft tissue, or surgical site infections should be cultured, ideally before antimicrobial therapy.


7. Catheter cultures: For suspected catheter-related bloodstream infections, paired quantitative blood cultures from the catheter and peripheral blood or differential time to positivity can establish the diagnosis.[19]


8. Joint aspiration: Synovial fluid analysis is essential when septic arthritis is suspected.


Novel Biomarkers and Techniques


1. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1): Shows promise as an early marker of bacterial infection with potentially higher specificity than conventional markers.[20]


2. Presepsin (sCD14-ST): A fragment of CD14 receptor, presepsin rises earlier than PCT in bacterial infections and may better reflect infection severity.[21]


3. Multiplex PCR systems: Rapid identification of pathogens and resistance genes from blood and other specimens, with results available within hours rather than days. A systematic review by Mancini et al. reported that molecular rapid diagnostic testing reduced time to appropriate antimicrobial therapy by 5-30 hours compared to conventional methods.[22]


4. Metagenomic next-generation sequencing: Allows for unbiased detection of all potential pathogens, including rare or fastidious organisms. Particularly valuable in culture-negative sepsis or immunocompromised hosts.[23]


5. Mass spectrometry: MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) enables pathogen identification directly from positive blood cultures within minutes, dramatically reducing identification time.[24]


 Imaging Studies for Source Identification


 Chest Imaging


1. Chest radiography: Usually the first imaging study in septic patients due to the high prevalence of pulmonary sources. However, sensitivity is limited, particularly in early pneumonia, immunocompromised patients, or dehydration.[25]


2. Chest computed tomography (CT): Superior to radiography for detecting lung parenchymal abnormalities, pleural effusions, empyema, lung abscesses, and mediastinitis. Self et al. demonstrated that chest CT identified pulmonary sources in 26% of patients with negative chest radiographs and clinical suspicion of pneumonia.[26]


 Abdominal and Pelvic Imaging


1. Abdominal ultrasonography: Useful first-line investigation for hepatobiliary and renal sources. Operator-dependent with limited sensitivity for retroperitoneal pathology.


2. Abdominal and pelvic CT: Gold standard for evaluating intra-abdominal sources with sensitivity >95% for most significant pathologies.[27] CT findings suggesting intra-abdominal infection include:

   - Free intraperitoneal air or fluid

   - Bowel wall thickening or pneumatosis intestinalis

   - Abscess formation

   - Appendiceal enlargement or inflammation

   - Diverticular inflammation with or without perforation

   - Pancreatic necrosis or peripancreatic fluid collections

   - Biliary ductal dilatation or gallbladder wall thickening


3. Magnetic resonance imaging (MRI): Superior for evaluating soft tissue infections, spinal or paraspinal infections, and hepatobiliary pathology when IV contrast is contraindicated.


4. Magnetic resonance cholangiopancreatography (MRCP): Superior to CT for detailed biliary tree evaluation in suspected cholangitis.


Cardiovascular Imaging


1. Echocardiography: Transthoracic echocardiography (TTE) should be considered in patients with persistent bacteremia, new murmur, embolic phenomena, or prosthetic heart valves. Transesophageal echocardiography (TEE) offers superior sensitivity (90-100%) for detecting valvular vegetations, paravalvular abscesses, and device-related infections.[28]


2. Vascular ultrasonography: For evaluating suspected thrombophlebitis or vascular access site infections.


 Central Nervous System Imaging


1. Brain CT or MRI: Indicated when central nervous system infection is suspected. MRI is more sensitive for early cerebritis, encephalitis, and small abscesses.[29]


Nuclear Medicine Studies


1. 18F-FDG PET/CT: Particularly valuable in identifying occult infection sources in patients with fever of unknown origin or culture-negative endocarditis, with reported sensitivity of 85-90% and specificity of 70-85%.[30]


2. Labeled leukocyte scintigraphy: Can help localize infection in challenging cases, particularly for vascular graft infections, osteomyelitis, and prosthetic joint infections.[31]


Special Considerations in Focus Identification


Immunocompromised Patients


Immunocompromised patients present unique challenges due to atypical presentations, opportunistic pathogens, and diminished inflammatory responses. Key considerations include:


1. Expanded microbial spectrum: Consider fungi (Candida, Aspergillus, Pneumocystis), viruses (CMV, HSV, VZV), mycobacteria, and Nocardia.


2. Lower threshold for advanced imaging: Liberal use of CT imaging is warranted given the higher likelihood of atypical presentations and opportunistic infections.


3. Invasive diagnostic procedures: Early consideration of bronchoscopy, tissue biopsy, or surgical exploration may be necessary for definitive diagnosis.


4. Type of immunosuppression: Different immunodeficiencies predispose to different infections. For example:

   - Neutropenia: Gram-negative bacteria, Pseudomonas, invasive fungal infections

   - T-cell defects (HIV, transplant): PCP, cryptococcus, mycobacteria, toxoplasmosis

   - B-cell defects: Encapsulated bacteria (pneumococcus, H. influenzae)

   - Splenectomy: Encapsulated organisms, babesiosis


Schmidt-Hieber et al. reported that systematic application of diagnostic protocols in febrile neutropenic patients increased infectious source identification from 55% to 78%, with corresponding improvements in targeted therapy.[32]

 Elderly Patients


Older adults frequently present with atypical manifestations of sepsis:


1. Blunted fever response: Only 30-50% of geriatric patients with serious infections present with fever.[33]


2. Non-specific presentations: Delirium, falls, decreased oral intake, or functional decline may be the only manifestations of infection.


3. High prevalence of chronic diseases: Comorbidities complicate interpretation of clinical and laboratory findings.


4. Polypharmacy: Medications like beta-blockers can mask tachycardia, and corticosteroids can suppress inflammatory responses.


Norman et al. found that implementing geriatric-specific sepsis screening protocols improved early source identification in elderly ED patients by 22%.[34]


Maternal Sepsis


Physiological changes of pregnancy alter sepsis presentation and source distribution:


1. Altered vital signs: Baseline tachycardia and reduced blood pressure complicate early recognition.


2. Pregnancy-specific sources: Chorioamnionitis, endometritis, septic abortion, and puerperal infections.


3. Unique considerations in imaging: Minimizing fetal radiation exposure while ensuring appropriate maternal evaluation.


The WHO Maternal Sepsis Study Group recommends systematic assessment for genital tract sources in all pregnant or recently pregnant women with suspected infection.[35]


Challenging and Uncommon Sources


1. Deep tissue infections: Necrotizing fasciitis, pyomyositis, and deep-seated abscesses may present with subtle findings despite significant tissue involvement.


2. Infective endocarditis: Consider in patients with persistent bacteremia, new murmur, embolic phenomena, or risk factors such as intravenous drug use or prosthetic valves.


3. Spinal infections: Vertebral osteomyelitis, discitis, and epidural abscesses often present with non-specific back pain, making early diagnosis challenging.


4. Implanted device infections: Pacemakers, defibrillators, ventricular assist devices, prosthetic joints, and vascular grafts can harbor biofilm-producing organisms with minimal local signs.


5. Sinusitis: Particularly in intubated patients, immunocompromised hosts, or those with nasogastric tubes.


6. Central nervous system infections: Especially in the elderly or immunocompromised where meningeal signs may be absent.


## Structured Approach to Source Identification in the ED


Based on the evidence reviewed, we propose a structured approach to source identification in septic patients presenting to the ED:


 Step 1: Rapid Initial Assessment (0-15 minutes)


1. Focused history and physical examination targeting common sources

2. Initial laboratory studies (CBC, basic metabolic panel, lactate)

3. Blood cultures (two sets) and urinalysis

4. Chest radiography


 Step 2: Expanded Evaluation (15-60 minutes)


1. Detailed system-specific examination based on initial findings

2. Additional laboratory studies (PCT, CRP, liver function, coagulation studies)

3. Source-directed cultures (urine, sputum, wounds, CSF as indicated)

4. First-line imaging studies based on clinical suspicion


 Step 3: Advanced Diagnostics (1-6 hours)


1. Cross-sectional imaging (CT, MRI) for suspected sources not identified by initial evaluation

2. Specialist consultation for system-specific assessment

3. Consideration of invasive diagnostic procedures (bronchoscopy, paracentesis, etc.)


 Step 4: Reevaluation and Refinement (6-24 hours)


1. Integration of microbiological and imaging results

2. Reassessment of clinical response to empirical therapy

3. Additional advanced diagnostics for persistent sepsis without clear source


Several studies have demonstrated improved outcomes with implementation of structured protocols. Jones et al. reported that implementation of a sepsis source identification bundle in the ED reduced time to source identification by 2.7 hours and was associated with a 15% reduction in hospital length of stay.[36]


Multidisciplinary Collaboration


Effective source identification often requires collaboration between emergency physicians, intensivists, infectious disease specialists, radiologists, and surgeons. A team-based approach facilitates:


1. Expert interpretation of complex imaging findings: Radiologist input significantly improves diagnostic accuracy in subtle imaging abnormalities.


2. Assessment of surgical source control needs: Early surgical consultation for potentially surgical sources facilitates timely intervention.


3. Infectious disease expertise: Particularly valuable for immunocompromised patients, culture-negative sepsis, or unusual pathogen consideration.


4. Integrated diagnostic planning: Coordinated approach to sequential or parallel diagnostic testing based on evolving clinical picture.


Koenig et al. demonstrated that implementation of multidisciplinary sepsis teams with standardized communication protocols improved source identification rates from 75% to 92% and reduced time to source control procedures by 3.5 hours.[37]


Challenges and Future Directions


Challenges in Source Identification


1. Time constraints: The ED environment presents challenges for comprehensive evaluation while balancing the need for rapid treatment initiation.


2. Resource limitations: Advanced imaging and diagnostic modalities may not be readily available in all settings or during off-hours.


3. Antimicrobial pretreatment: Prior antimicrobial exposure reduces culture positivity, complicating microbiological confirmation.


4. Non-infectious mimics of sepsis: Conditions such as adrenal insufficiency, thyroid storm, malignant hyperthermia, and autoimmune disorders can present with sepsis-like syndromes.


Future Directions


1. Point-of-care diagnostics: Rapid molecular testing platforms in the ED could revolutionize early pathogen identification and resistance detection.


2. Artificial intelligence applications: Machine learning algorithms integrating clinical, laboratory, and imaging data show promise for predicting likely infection sources and guiding diagnostic pathways.[38]


3. Host response profiling: Transcriptomic and metabolomic signatures may differentiate infection types and guide targeted diagnostics.


4. Novel imaging techniques: Dual-energy CT, advanced MRI sequences, and hybrid imaging technologies may improve detection of occult infection foci.


5. Biomarker panels: Combinations of biomarkers assessing different aspects of the host response may improve specificity for infection localization.


 Conclusion


Identifying the source of infection in septic patients remains a critical determinant of effective management and patient outcomes. A systematic approach combining thorough clinical evaluation, appropriate laboratory investigations, and judicious use of imaging studies optimizes source identification in the emergency setting. Special attention to high-risk populations and challenging sources, coupled with multidisciplinary collaboration and structured protocols, can further improve diagnostic accuracy and efficiency. As diagnostic technologies continue to evolve, emergency medicine practitioners must maintain a high index of suspicion and methodical approach to source identification, balancing the imperative for timely empirical treatment with the need for targeted therapy based on specific source identification.


References


1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.


2. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211.


3. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-377.


4. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063-e1143.


5. Gupta S, Sakhuja A, Kumar G, et al. Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes. Chest. 2016;150(6):1251-1259.


6. Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136(5):1237-1248.


7. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344-353.


8. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4-11.


9. Leisman DE, Doerfler ME, Ward MF, et al. Survival Benefit and Cost Savings From Compliance With a Simplified 3-Hour Sepsis Bundle in a Series of Prospective, Multisite, Observational Cohorts. Crit Care Med. 2017;45(3):395-406.


10. Phua J, Ngerng WJ, See KC, et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013;17(5):R202.


11. Pradipta IS, Sodik DC, Lestari K, et al. Antibiotic resistance in sepsis patients: evaluation and recommendation of antibiotic use. N Am J Med Sci. 2013;5(6):344-352.


12. Peterson M, Gurley D, Feng G, et al. The Impact of a Structured Physical Examination Protocol on Infectious Source Identification in Emergency Department Sepsis Patients. J Emerg Med. 2021;60(3):335-343.


13. Drees M, Kanapathippillai N, Zubrow MT. Bandemia with normal white blood cell counts associated with infection. Am J Med. 2012;125(11):1124.e9-1124.e15.


14. Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10(10):CD007498.


15. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-435.


16. Coburn B, Morris AM, Tomlinson G, Detsky AS. Does this adult patient with suspected bacteremia require blood cultures? JAMA. 2012;308(5):502-511.


17. Lee SH, Ruan SY, Pan SC, et al. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the diagnosis of pneumonia and acute respiratory infections. PLoS One. 2021;16(2):e0246669.


18. Leber AL, Everhart K, Balada-Llasat JM, et al. Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens. J Clin Microbiol. 2016;54(9):2251-2261.


19. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.


20. Gibot S, Béné MC, Noel R, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med. 2012;186(1):65-71.


21. Endo S, Suzuki Y, Takahashi G, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18(6):891-897.


22. Mancini N, Carletti S, Ghidoli N, et al. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev. 2010;23(1):235-251.


23. Grumaz S, Stevens P, Grumaz C, et al. Next-generation sequencing diagnostics of bacteremia in septic patients. Genome Med. 2016;8(1):73.


24. Idelevich EA, Schüle I, Grünastel B, et al. Rapid identification of microorganisms from positive blood cultures by MALDI-TOF mass spectrometry subsequent to very short-term incubation on solid medium. Clin Microbiol Infect. 2014;20(10):1001-1006.


25. Self WH, Courtney DM, McNaughton CD, et al. High discordance of chest x-ray and computed tomography for detection of pulmonary opacities in ED patients: implications for diagnosing pneumonia. Am J Emerg Med. 2013;31(2):401-405.


26. Self WH, Barrett TW, Fowler RF, et al. Limited utility of chest radiograph in initial diagnosis of pneumonia in adult emergency department patients. Ann Am Thorac Soc. 2021;18(1):91-99.


27. Go J, Vazquez MN, Brant W, et al. Accuracy and clinical value of abdominal CT findings in patients with sepsis of unknown source. Abdom Radiol (NY). 2021;46(3):1142-1151.


28. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075-3128.


29. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-1284.


30. Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation--current and emerging clinical applications. Clin Radiol. 2015;70(7):787-800.


31. Palestro CJ. Radionuclide imaging of infection: in search of the grail. J Nucl Med. 2009;50(5):671-673.


32. Schmidt-Hieber M, Teschner D, Maschmeyer G, Schalk E. Management of febrile neutropenia in special consideration of the role of antimicrobial de-escalation. Expert Rev Anti Infect Ther. 2019;17(12):983-995.


33. Norman DC. Clinical Features of Infection in Older Adults. Clin Geriatr Med. 2016;32(3):433-441.


34. Norman DC, Yoshikawa TT. Fever in the elderly. Infect Dis Clin North Am. 1996;10(1):93-99.


35. Bonet M, Pileggi VN, Rijken MJ, et al. Towards a consensus definition of maternal sepsis: results of a systematic review and expert consultation. Reprod Health. 2017;14(1):67.


36. Jones SL, Ashton CM, Kiehne L, et al. Reductions in Sepsis Mortality and Costs After Design and Implementation of a Nurse-Based Early Recognition and Response Program. Jt Comm J Qual Patient Saf. 2015;41(11):483-491.


37. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19(4):637-657.


38. Islam MM, Nasrin T, Walther BA, et al. Prediction of sepsis patients using machine learning approach: A meta-analysis. Comput Methods Programs Biomed. 2019;170:1-9.

When to Say No to ICU Admission

  When to Say No to ICU Admission: Consultant-Level Triage Decision-Making in Critical Care Dr Neeraj Manikath, Claude.ai Abstract Backgroun...